Search - tctmd.com

Displaying 121 - 140 of 344

Sort: Relevancy | Date

News Daily News

For Real-world ACS Patients, FFR Use in PCI Tied to Lower In-Hospital Mortality

Michael O'Riordan

December 05, 2019

News Conference News AHA 2019

More Adverse Events, Higher Costs With Impella: New Observational Studies

Caitlin E. Cox

November 17, 2019

News Conference News AHA 2019

Aspirin Discontinuation Safe, Effective Strategy in ACS Subset: TWILIGHT

Yael L. Maxwell

November 17, 2019

News Daily News

Upfront Imaging Reduces Invasive Angiography in Patients With Unclear NSTEMI Diagnosis

Michael O'Riordan

November 11, 2019

News Daily News

Believing SCOT-HEART: New Analysis Probes Plausible Mechanisms of Benefit

Shelley Wood

October 14, 2019

News Daily News

Dramatic Swings in Household Income Linked to CVD Risk: ARIC

Michael O'Riordan

October 09, 2019

News Conference News TCT 2019

Tailored Hydration Strategy Cuts Contrast-Induced Kidney Injury: REMEDIAL III

Michael O'Riordan

October 03, 2019

Off Script: A (Not So) Brief History of Aspirin’s Rise and Fall

News Opinion Off Script TCT 2019

Off Script: The TWILIGHT of Aspirin? A Brief History of ASA’s Rise and Fall

Kwan S. Lee

September 29, 2019

News Conference News TCT 2019

New COMPLETE Data Affirm Benefit of Nonculprit PCI in STEMI Regardless of Timing

Todd Neale

September 28, 2019

News Conference News TCT 2019

TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events

Yael L. Maxwell

September 26, 2019

News Industry News

CeleCor Therapeutics Announces Positive First-in-Human Data of RUC-4, a Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor, Presented at TCT 2019

September 25, 2019

News Conference News ESC 2019

COMPLETE Beats Culprit-Only PCI in Multivessel STEMI and Timing Doesn’t Matter

Yael L. Maxwell

September 01, 2019

News Daily News

Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES

Michael O'Riordan

August 26, 2019

News Daily News

CEC Identifies ‘Prognostically Important’ MIs: CHAMPION PHOENIX

Michael O'Riordan

July 30, 2019

News Daily News

Bleeding, Myocardial Injury Are Key Drivers of Deaths After Noncardiac Surgery

Michael O'Riordan

July 29, 2019

News Daily News

Intensive Lipid-Lowering Slashes CVD in Elderly ACS Patients

Michael O'Riordan

July 19, 2019

News Conference News SCCT 2019

Doubling Down on SCOT-HEART: Mechanisms, Applicability, and Future Directions

Yael L. Maxwell

July 18, 2019

News Daily News

Evolut Valves: Initial Positioning Can Be Optimized for Future Coronary Access

Michael O'Riordan

July 10, 2019

News Daily News

Hybrid Revascularization for Multivessel CAD Rarely Used in the US

Todd Neale

July 04, 2019

News Daily News

Field in Flux: What’s the Best Antithrombotic Strategy for A-fib Patients Undergoing PCI?

Michael O'Riordan

July 03, 2019

Advertisement

For Real-world ACS Patients, FFR Use in PCI Tied to Lower In-Hospital Mortality

More Adverse Events, Higher Costs With Impella: New Observational Studies

Aspirin Discontinuation Safe, Effective Strategy in ACS Subset: TWILIGHT

Upfront Imaging Reduces Invasive Angiography in Patients With Unclear NSTEMI Diagnosis

Believing SCOT-HEART: New Analysis Probes Plausible Mechanisms of Benefit

Dramatic Swings in Household Income Linked to CVD Risk: ARIC

Tailored Hydration Strategy Cuts Contrast-Induced Kidney Injury: REMEDIAL III

Off Script: The TWILIGHT of Aspirin? A Brief History of ASA’s Rise and Fall

New COMPLETE Data Affirm Benefit of Nonculprit PCI in STEMI Regardless of Timing

TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events

CeleCor Therapeutics Announces Positive First-in-Human Data of RUC-4, a Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor, Presented at TCT 2019

COMPLETE Beats Culprit-Only PCI in Multivessel STEMI and Timing Doesn’t Matter

Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES

CEC Identifies ‘Prognostically Important’ MIs: CHAMPION PHOENIX

Bleeding, Myocardial Injury Are Key Drivers of Deaths After Noncardiac Surgery

Intensive Lipid-Lowering Slashes CVD in Elderly ACS Patients

Doubling Down on SCOT-HEART: Mechanisms, Applicability, and Future Directions

Evolut Valves: Initial Positioning Can Be Optimized for Future Coronary Access

Hybrid Revascularization for Multivessel CAD Rarely Used in the US

Field in Flux: What’s the Best Antithrombotic Strategy for A-fib Patients Undergoing PCI?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content